News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
ORBIMED ADVISORS LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on NeuroPace Inc|
Txns:
| Sold 7,614 shares
@ $9.08, valued at
$69.1k
Sold 700 shares
@ $9.02, valued at
$6.3k
|
|
| 08/17/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Sold 38,327 shares
@ $0.75, valued at
$28.7k
Sold 248,819 shares
@ $0.75, valued at
$186.6k
Sold 535,534 shares
@ $0.75, valued at
$401.7k
|
|
| 08/02/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Sold 26,622 shares
@ $3, valued at
$79.9k
Sold 29,700 shares
@ $3, valued at
$89.1k
Sold 153,078 shares
@ $3, valued at
$459.2k
|
|
| 07/27/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Sold 7,800 shares
@ $2.92, valued at
$22.8k
Sold 4,700 shares
@ $2.92, valued at
$13.7k
Sold 26,700 shares
@ $2.92, valued at
$78k
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Sold 9,800 shares
@ $2.4, valued at
$23.5k
Sold 52,800 shares
@ $2.4, valued at
$126.7k
Sold 132,100 shares
@ $2.4, valued at
$317k
|
|
| 06/29/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Bought 125,000 shares
@ $2.09, valued at
$261.3k
Bought 250,000 shares
@ $2.09, valued at
$522.5k
Bought 442,000 shares
@ $2.09, valued at
$923.8k
Bought 58,000 shares
@ $2.09, valued at
$121.2k
|
|
| 06/29/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Bought 617,382 shares
@ $0.84, valued at
$518.6k
Bought 575,195 shares
@ $0.84, valued at
$483.2k
|
|
| 05/24/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Bought 869,565 shares
@ $5.75, valued at
$5M
|
|
| 05/19/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Exercised 2,125 options to buy
@ $4.28, valued at
$9.1k
|
|
| 05/15/2023 |
4
| ORBIMED ADVISORS LLC (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 80,000 shares
@ $22.26, valued at
$1.8M
Sold 43,200 shares
@ $21.64, valued at
$934.8k
Sold 14,400 shares
@ $21.96, valued at
$316.2k
Sold 345,313 shares
@ $20, valued at
$6.9M
|
|
| 05/08/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Bought 83,459 shares
@ $2.75, valued at
$229.5k
Bought 312,991 shares
@ $2.75, valued at
$860.7k
Bought 83,459 shares
@ $2.75, valued at
$229.5k
Bought 490,512 shares
@ $2.82, valued at
$1.4M
Bought 490,511 shares
@ $2.82, valued at
$1.4M
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Granted 7,611,458 shares
@ $0
Granted 288,114 shares
@ $0 |
|
| 02/23/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 550,000 shares
@ $0
Granted 550,000 shares
@ $0 |
|
| 01/03/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Acquired 284,876 shares
@ $0
Acquired 582,622 shares
@ $0
Acquired 153,936 shares
@ $0
Acquired 1,139,507 shares
@ $0 |
|
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2022 |
4
| ORBIMED ADVISORS LLC (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 3,284,800 shares
@ $21.71, valued at
$71.3M
Sold 684,696 shares
@ $22.07, valued at
$15.1M
Sold 961,328 shares
@ $22.27, valued at
$21.4M
Sold 1,116,048 shares
@ $23.23, valued at
$25.9M
Sold 92,992 shares
@ $24.11, valued at
$2.2M
|
|
| 11/29/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Bought 762,380 shares
@ $5.25, valued at
$4M
|
|
| 11/25/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Tricida, Inc.|
Txns:
| Sold 1,034,421 shares
@ $0.22, valued at
$227.6k
Sold 5,617,300 shares
@ $0.21, valued at
$1.2M
Sold 3,629,226 shares
@ $0.22, valued at
$798.4k
|
|
| 11/10/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 402,000 shares
@ $3.21, valued at
$1.3M
|
|
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Third Harmonic Bio, Inc.|
Txns:
| Converted 5,479,071 shares
@ $0
Bought 300,000 shares
@ $17, valued at
$5.1M
Converted 8,593,750 preferred shares
@ $0
Converted 2,441,407 options to buy
@ $0
Converted 1,342,065 preferred shares
@ $0 |
|
| 09/16/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Bought 484,496 shares
@ $10.32, valued at
$5M
|
|
| 09/14/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 123,897 shares
@ $31.96, valued at
$4M
Sold 30,000 shares
@ $31.98, valued at
$959.4k
|
|
| 08/18/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 2,470,200 shares
@ $2.42, valued at
$6M
Bought 457,400 shares
@ $2.42, valued at
$1.1M
Bought 762,400 shares
@ $2.42, valued at
$1.8M
Bought 207,500 options to buy
@ $0
Bought 38,450 options to buy
@ $0
Bought 64,050 options to buy
@ $0 |
|
| 08/17/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Acquired 215,415 shares
@ $0 |
|
| 08/10/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 205,000 shares
@ $38.33, valued at
$7.9M
Sold 69,568 shares
@ $37.47, valued at
$2.6M
|
|
| 07/01/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 1,511,362 shares
@ $55, valued at
$83.1M
Disposed/sold 226,704 shares
@ $55, valued at
$12.5M
Disposed/sold 1,136,250 options to buy
@ $13.2, valued at
$15M
Disposed/sold 170,437 options to buy
@ $13.2, valued at
$2.2M
|
|
| 06/28/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 306,027 shares
@ $21.31, valued at
$6.5M
Sold 35,944 shares
@ $21.31, valued at
$766k
|
|
| 06/24/2022 |
4
| ORBIMED ADVISORS LLC (Director) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Bought 66,806 shares
@ $3.55, valued at
$237.2k
Bought 23,419 shares
@ $3.71, valued at
$86.9k
Bought 65,965 shares
@ $4.37, valued at
$288.3k
Bought 96,035 shares
@ $5.37, valued at
$515.7k
|
|
|
|
|